494 results on '"Graupera, Isabel"'
Search Results
2. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis
3. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
4. Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals
5. Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
6. Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling
7. Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
8. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
9. Position paper of the Catalan Society of Gastroenterology about hepatic elastography 2022
10. Documento de posicionamiento de la «Societat Catalana de Digestologia» sobre elastografía hepática 2022
11. Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
12. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
13. A global research priority agenda to advance public health responses to fatty liver disease
14. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease
15. Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas»
16. WED-155 A ratio of exchangeable copper below 15% accurately excludes Wilson disease and may be useful for the first-line ethiologic work-up within a liver unit
17. WED-181 Use of metallothionein 1 as an ancillary tool for the diagnosis of Wilson disease
18. OS-059 Unveiling Socioeconomic Disparities on Liver Disease: A Comparative Study of ALD, MASLD, and MetALD Patients
19. TOP-241-YI Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants
20. FRI-211 The presence of autoimmune characteristics in metabolic associated steatosis liver disease patients increases the risk of liver disease progression. Study from the multicentric spanish register (HEPAMET)
21. WED-284-YI The Fatty Liver Index (FLI) is more accurate than FIB-4 for detection of advanced liver fibrosis in patients with type-2 Diabetes Mellitus (T2DM) in Primary Care
22. FRI-219-YI Recompensation and liver function improvement in patients with decompensated cirrhosis due to metabolic-dysfunction associated steatotic liver disease (MASLD): a retrospective cohort study
23. THU-056 Soluble PD-L1 levels as predictors of ACLF in decompensated cirrhosis: findings from two independent cohorts
24. OS-005-YI Single-cell RNA sequencing analysis in alcohol-related liver disease identifies specific cell subpopulations characterized by an inflammatory profile in alcohol-associated hepatitis
25. WED-055 Effect of long-term treatment with Simvastatin and Rifaximin in mitochondrial and proinflammatory pathways in patients with decompensated cirrhosis. A single-cell RNA seq analysis in PBMCs
26. Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosis
27. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
28. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
29. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease
30. Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
31. LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
32. Screening for fibrosis to diagnose liver diseases early: the LIVERSCREEN project
33. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
34. Trajectory analysis of hepatic stellate cell differentiation reveals metabolic regulation of cell commitment and fibrosis
35. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF)
36. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure
37. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis
38. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
39. Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation
40. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
41. LiverPRO for the Prediction of Significant Liver Fibrosis in Primary Care: Development, Validation, and Prognostic Evaluation of a Novel Score
42. Screening for fibrosis promotes life-style changes. A prospective cohort study in 4,796 individuals
43. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia
44. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial
45. Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The LiverKids: Study protocol
46. Position paper of the Catalan Society of Gastroenterology about hepatic elastography 2022
47. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
48. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study
49. Patients with alcohol-related cirrhosis who recompensate on follow-up have a characteristic metabolomic profile with differential concentrations of lipid and amino-acid metabolites
50. Perivascular macrophages contribute to adipose tissue angiogenesis in patients with advanced non-alcoholic fatty liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.